Cite

HARVARD Citation

    Zhou, J. et al. (n.d.). Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation. Leukemia & lymphoma. 56 (11), pp. 3207-3209. [Online]. 
  
Back to record